ClinicalTrials.gg
RecruitingNCT05390268Updated Feb 21, 2025

Mobile App-assisted Behavioral Treatment in Children and Adolescents With Tics

An interventional study of Mobile app-assisted behavioral treatment and Mobile app-assisted psychoeducation in Tic Disorders, sponsored by Aarhus University Hospital. Recruiting at 1 site in Denmark. Open to participants aged 9 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-02-21.

Sponsored by Aarhus University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Apr 2022; still recruiting 4 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
9 Years to 17 Years
Sex
All
01

Study summary

Chronic tic disorders are neurodevelopmental disorders affecting 0.5-1% of children and adolescents. Tics present as sudden, rapid, repetitive non-rhythmic movements or vocalizations or a combination. Tics may be extremely distressing in a child's life, but the severity of tics is often variable. The group of children/ adolescents with tic disorders are heterogenous when it comes to symptom presentation, comorbid conditions and social status. This places great demands on professionals to offer the right treatment at the right time. The aim of the current project is to make optimal tics training more accessible, including for patients managed in primary care, to make optimal treatment available in the immediate environment, and to ensure increased adherence to treatment.

As part of this project, an app has been developed and the study aims to evaluate mobile app-assisted behavioral treatment as an efficient and feasible approach that may be a valuable tool together with other treatment approaches. The mobile app-assisted training is based on the manual "Niks til Tics", which describes training with a combination of Habit Reversal Training (HRT) and Exposure Response Prevention (ERP) over eight sessions, and a booster session. Both HRT and ERP are known to be effective treatments of tics.

In this project a randomized controlled superiority trial evaluates the effect of app-assisted training versus an educational approach. Participants are randomized to manualised treatment combining HRT and ERP as app-assisted training, or to psychoeducation. The participants are included according to the same criteria as in a pilot trial, and primary outcome measure is YGTSS at session 8. Furthermore, the change in tics intensity from the first contact to baseline will be included as to evaluate the effect of being admitted and examined at the hospital.

This project contributes to increased knowledge about tics and tic treatment especially treatment using digital based interventions. An app has been developed for this project and the hypothesis is that a mobile app-assisted tic training program requiring minimal hospital contacts is superior to app-based psychoeducation alone, which is the most likely intervention that these patients will be offered.

This registration encompasses a project that collects information/data for multiple publications. As such, a number of publications are planned including a description of acute outcome, potential predictors, and longterm treatment effect

02

Conditions studied

  • Tic Disorders

Browse trials for

Keywords

  • tics
  • children
  • adolescents
  • Mobile app-assisted behavioral treatment
03

In context

Tic Disorders

102 studies on the registry are indexed under Tic Disorders; 26 are open to participants now.

This study's planned enrollment of 60 is above the median of 50 across 83 interventional studies indexed under Tic Disorders.

Browse Tic Disorders studies →

Lead sponsor

Aarhus University Hospital is the lead sponsor of 298 studies on the registry; 80 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • a primary diagnosis of a chronic motor/vocal tics disorder including Tourette syndrome according to the WHO ICD-10 diagnostic criteria and Statistical Manual of Mental Disorders
  • a total tic score higher than 13 on the Yale Global Tic Severity Scale (YGTSS), or above a tic score of 9, if only motor or vocal tics are present

Exclusion criteria

Exclusion Criteria:

  • psychotic disorder
  • primary severe depression
  • suicidal ideation or attempts
  • primary severe eating disorder
  • IQ below 70 (mental retardation)
  • participation in tic training based on HRT/ERP treatment within 6 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    digital tic training

    The active treatment including apps released for every session

    Behavioral: Mobile app-assisted behavioral treatment

  • Active comparator
    digital tic learner

    The control arm including apps released in the first session

    Other: Mobile app-assisted psychoeducation

Interventions

  • BehavioralMobile app-assisted behavioral treatment

    The app-assisted training group has access to a newly developed app in which they are taught how to handle tics. A new app session is released at each new treatment session and the content of the app videos is comparable to the information and training at face-to-face individual treatment, as defined by the manual "Niks to Tics"\[

  • OtherMobile app-assisted psychoeducation

    The app-assisted educational group has access to a newly developed app in which they receive psychoeducation on tics.

06

What researchers measure

Primary outcomes

  1. Change of baseline Yale Global Tic Severity Scale (YGTSS) at 5 weeks, 15 weeks, 23 weeks, 75-96 weeks

    YGTSS - a clinician-administered semi-structured interview including a checklist of all tic symptoms

    Time frame: Baseline, 5 weeks, 15 weeks, 23 weeks, 75-96 weeks

Secondary outcomes

  1. Change of baseline premonitory urge scale (PUTS)

    PUTS is a short self-reporting scale with nine items

    Time frame: Baseline, 5 weeks, 15 weeks, 23 weeks, 75-96 weeks

  2. Change of baseline beliefs about tics scale (BATS)

    BATS is a self-reporting scale with 20 items

    Time frame: Baseline, 5 weeks, 15 weeks, 23 weeks, 75-96 weeks

  3. Change of baseline parent and child self-evaluating questionnaire

    Based on PTQ - a parent evaluating questionnaire

    Time frame: Baseline, 5 weeks, 15 weeks, 23 weeks, 75-96 weeks

07

Study locations

1 of 1 sites recruiting
  • AarhusUH
    Aarhus N, Risskov 8240, Denmark
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05390268
Responsible party
Judith Becker Nissen (associate professor, phd, senior doctor, Aarhus University Hospital) — Principal investigator
First posted
May 25, 2022
Start date
Apr 1, 2022
Primary completion
Oct 31, 2025 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Feb 21, 2025

Study contacts

judith nissen, phd
Contact
judiniss@rm.dk
+4529931523
Per Thomsen, Phd
study chair · Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Psychiatry, Aarhus, Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion